封面
市場調查報告書
商品編碼
1387492

轉染試劑與設備市場報告:2030 年趨勢、預測與競爭分析

Transfection Reagent and Equipment Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

轉染試劑和設備的趨勢和預測

預計到 2030 年,全球轉染試劑和設備市場將達到 19 億美元,2024 年至 2030 年年複合成長率為 6.5%。該市場的主要驅動力是全球慢性疾病負擔的增加、對合成基因的高需求以及轉染技術的進步。全球轉染試劑和設備市場的未來前景廣闊,學術和研究機構以及製藥和生物技術公司市場存在商機。

轉染試劑和設備市場洞察

Lucintel 預測,隨著主要企業推出許多產品以擴大其試劑產品組合的廣度,預計試劑在預測期內將出現高速成長。

在這個市場中,由於疾病負擔的增加以及試劑和設備在全球範圍內的採用不斷增加,製藥和生物技術公司將繼續成為最大的細分市場。

由於基因組學研究和開發投資的增加、蛋白質治療藥物需求的增加以及該地區領先公司的存在,北美在預測期內可能仍是最大的市場。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球轉染試劑與設備市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球轉染試劑和設備市場趨勢(2018-2023)和預測(2024-2030)
  • 全球轉染試劑和設備市場(按產品)
    • 試劑
    • 裝置
  • 按方法分類的全球轉染試劑和設備市場
    • 物理方法
    • 生化方法
    • 病毒法
  • 全球轉染試劑和設備市場(按應用)
    • 蛋白質生產
    • 生化研究
    • 提供治療方法
  • 以最終用途分類的全球轉染試劑和設備市場
    • 學術/研究機構
    • 製藥和生物技術公司
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球轉染試劑和設備市場(按地區)
  • 北美轉染試劑及設備市場
  • 歐洲轉染試劑及設備市場
  • 亞太轉染試劑及設備市場
  • 其他地區轉染試劑及設備市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球轉染試劑和設備市場成長機會(按產品)
    • 按方法分類的全球轉染試劑和設備市場成長機會
    • 全球轉染試劑和設備市場成長機會(按應用)
    • 按最終用途分類的全球轉染試劑和設備市場的成長機會
    • 全球轉染試劑和設備市場按地區成長機會
  • 全球轉染試劑及設備市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球轉染試劑和設備市場的產能
    • 全球轉染試劑和設備市場的合併、收購和合資
    • 認證和許可

第7章 主要企業概況

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen NV
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche
簡介目錄

Transfection Reagent and Equipment Trends and Forecast

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

A more than 150-page report is developed to help in your business decisions.

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents
  • Equipment

Transfection Reagent and Equipment Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Physical Methods
  • Biochemical Methods
  • Viral Methods

Transfection Reagent and Equipment Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Protein Production
  • Biomedical Research
  • Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academics & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Transfection Reagent and Equipment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Transfection Reagent and Equipment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transfection reagent and equipment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen N.V.
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche

Transfection Reagent and Equipment Market Insights

Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Within this market, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.

North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the transfection reagent and equipment market size?

Answer: The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for transfection reagent and equipment market?

Answer: The global transfection reagent and equipment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the transfection reagent and equipment market?

Answer: The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

Q4. What are the major segments for transfection reagent and equipment market?

Answer: The future of the transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets.

Q5. Who are the key transfection reagent and equipment market companies?

Answer: Some of the key transfection reagent and equipment companies are as follows:

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen N.V.
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche

Q6. Which transfection reagent and equipment market segment will be the largest in future?

Answer: Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Q7. In transfection reagent and equipment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transfection Reagent and Equipment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transfection Reagent and Equipment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transfection Reagent and Equipment Market by Product
    • 3.3.1: Reagents
    • 3.3.2: Equipment
  • 3.4: Global Transfection Reagent and Equipment Market by Method
    • 3.4.1: Physical Methods
    • 3.4.2: Biochemical Methods
    • 3.4.3: Viral Methods
  • 3.5: Global Transfection Reagent and Equipment Market by Application
    • 3.5.1: Protein Production
    • 3.5.2: Biomedical Research
    • 3.5.3: Therapeutic Delivery
  • 3.6: Global Transfection Reagent and Equipment Market by End Use
    • 3.6.1: Academics & Research Institutes
    • 3.6.2: Pharmaceutical & Biotechnology Companies
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transfection Reagent and Equipment Market by Region
  • 4.2: North American Transfection Reagent and Equipment Market
    • 4.2.2: North American Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.3: European Transfection Reagent and Equipment Market
    • 4.3.1: European Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.3.2: European Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.4: APAC Transfection Reagent and Equipment Market
    • 4.4.1: APAC Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.4.2: APAC Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.5: ROW Transfection Reagent and Equipment Market
    • 4.5.1: ROW Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.5.2: ROW Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Product
    • 6.1.2: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Method
    • 6.1.3: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Application
    • 6.1.4: Growth Opportunities for the Global Transfection Reagent and Equipment Market by End Use
    • 6.1.5: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Region
  • 6.2: Emerging Trends in the Global Transfection Reagent and Equipment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transfection Reagent and Equipment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transfection Reagent and Equipment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: PromoCell
  • 7.2: OriGene Technologies
  • 7.3: Thermo Fisher Scientific
  • 7.4: Merck
  • 7.5: Bio-Rad Laboratories
  • 7.6: Lonza
  • 7.7: Qiagen N.V.
  • 7.8: Mirus Bio
  • 7.9: Promega Corporation
  • 7.10: F. Hoffmann-La Roche